XML 16 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2014
Fair Value of Financial Instruments [Abstract]  
Fair value of financial instruments
Following is a summary of the Company's financial instruments which have been valued at fair value in the Company's Consolidated Balance Sheets at September 30, 2014 and December 31, 2013:

  
Fair Value Based on Quoted Prices in Active Markets for Identical Assets
(Level 1)
  
Fair Value Based on Significant Other Observable Inputs
(Level 2)
  
Total
 
(in millions)
 
2014
  
2013
  
2014
  
2013
  
2014
  
2013
 
             
Cash and cash equivalents:
            
Cash
 
$
497
  
$
618
  
$
  
$
  
$
497
  
$
618
 
Money market funds
  
493
   
1,172
   
   
   
493
   
1,172
 
Commercial paper
  
   
   
21
   
4
   
21
   
4
 
U.S. corporate obligations
  
11
   
   
   
   
11
     
Non-U.S. bank and other obligations
  
36
   
19
   
   
   
36
   
19
 
Short-term investments:
                        
Commercial paper
  
   
   
9
   
   
9
   
 
U.S. Treasury securities
  
71
   
41
   
   
   
71
   
41
 
U.S. corporate obligations
  
35
   
   
   
   
35
   
 
Non-qualified plan assets:
                        
Money market funds
  
1
   
1
   
   
   
1
   
1
 
Domestic bond funds
  
3
   
3
   
   
   
3
   
3
 
Domestic equity funds
  
6
   
5
   
   
   
6
   
5
 
International equity funds
  
3
   
3
   
   
   
3
   
3
 
Blended equity funds
  
5
   
4
   
   
   
5
   
4
 
Common stock
  
2
   
2
   
   
   
2
   
2
 
Derivatives, net asset (liability):
                        
Foreign currency contracts
  
   
   
(43
)
  
19
   
(43
)
  
19
 
  
$
1,163
  
$
1,868
  
$
(13
)
 
$
23
  
$
1,150
  
$
1,891
 
Open derivative contracts
Total gross volume bought (sold) by notional currency and maturity date on open derivative contracts at September 30, 2014 was as follows (in millions):

  
Notional Amount - Buy
  
Notional Amount - Sell
 
  
2014
  
2015
  
2016
  
2017
  
Total
  
2014
  
2015
  
2016
  
Total
 
Foreign exchange forward contracts - 
                 
Notional currency in: 
                 
Euro 
 
103
   
79
   
14
   
   
196
   
(44
)
  
(5
)
  
(1
)
  
(50
)
Malaysian ringgit 
 
46
   
260
   
3
   
   
309
   
   
(20
)
  
   
(20
)
Norwegian krone 
 
293
   
675
   
103
   
4
   
1,075
   
(70
)
  
(69
)
  
   
(139
)
Pound sterling 
 
97
   
23
   
5
   
   
125
   
(52
)
  
(22
)
  
(1
)
  
(75
)
U.S. dollar 
 
29
   
7
   
   
   
36
   
(330
)
  
(456
)
  
(47
)
  
(833
)
                                     
Foreign exchange option contracts - 
                                   
Notional currency in: 
                                   
Euro 
 
29
   
87
   
   
   
116
   
   
   
   
 
Fair values of derivative financial instruments
The fair values of derivative financial instruments recorded in the Company's Consolidated Condensed Balance Sheets at September 30, 2014 and December 31, 2013 were as follows (in millions):

  
September 30, 2014
  
December 31, 2013
 
  
Assets
  
Liabilities
  
Assets
  
Liabilities
 
         
Derivatives designated as hedging instruments:
        
Current
 
$
6
  
$
34
  
$
28
  
$
10
 
Non-current
  
1
   
6
   
3
   
2
 
Total derivatives designated as hedging instruments
  
7
   
40
   
31
   
12
 
                 
Derivatives not designated as hedging instruments:
                
Current
  
3
   
13
   
6
   
6
 
Non-current
  
   
   
   
 
Total derivatives not designated as hedging instruments
  
3
   
13
   
6
   
6
 
                 
Total derivatives
 
$
10
  
$
53
  
$
37
  
$
18
 
Pre-tax gain (loss) from ineffective portion of derivatives
The amount of pre-tax gain (loss) from the ineffective portion of derivatives designated as hedging instruments and from derivatives not designated as hedging instruments was (in millions):

  
Three Months Ended
  
Nine Months Ended
 
  
September 30,
  
September 30,
 
  
2014
  
2013
  
2014
  
2013
 
         
Derivatives designated as hedging instruments -
        
Cost of sales
 
$
(4
)
 
$
3
  
$
(3
)
 
$
2
 
                 
Derivatives not designated as hedging instruments -
                
Cost of sales
  
(6
)
  
7
   
(4
)
  
3
 
Other costs
  
(4
)
  
(1
)
  
(4
)
  
(1
)
  
$
(14
)
 
$
9
  
$
(11
)
 
$
4